Natco Pharma Gets US FDA Tentative Approval For Olaparib Generic

18 July 2026

Natco Pharma Ltd.

Natco received US FDA tentative approval for Olaparib tablets (100mg, 150mg), a generic of Lynparza, with estimated US sales of $1.4B. Partner Alembic will distribute. Para IV litigation is ongoing.